NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

人体微生物治疗药的全球市场:至2030年的机会及策略 - COVID-19成长与变化

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

出版商 The Business Research Company 商品编码 980120
出版日期 内容资讯 英文 181 Pages
商品交期: 2-3个工作天内
价格
人体微生物治疗药的全球市场:至2030年的机会及策略 - COVID-19成长与变化 Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change
出版日期: 2020年12月31日内容资讯: 英文 181 Pages
简介

本报告提供全球人体微生物治疗药市场的相关调查,市场规模和预测,趋势和策略,成长及阻碍因素,COVID-19的影响,各疾病、定序技术类型、地区的市场分析,竞争情形,主要企业的简介等资讯。

目录

第1章 摘要整理

第2章 目录

第3章 图的清单

第4章 表格的清单

第5章 报告结构

第6章 简介

  • 地区市场区隔

第7章 人体微生物治疗药市场特征

  • 市场定义
  • 各疾病市场区隔
    • 感染疾病
    • 肠胃障碍
    • 代谢障碍
    • 癌症
    • 其他
  • 各定序技术类型市场区隔
    • 标的遗传基因
    • RNA
    • 全基因序列(WGS)-霰弹枪
    • 其他

第8章 市场趋势与策略

  • 策略性合作与协定
  • 开发平台研究和医药品开发数的增加
  • 癌症微生物治疗药的开发的投资增加

第9章 COVID-19的影响

第10章 市场规模与成长

  • 市场销售额成长预测(2023-2030)
    • 市场成长要素
    • 阻碍市场要素

第11章 市场分析:各地区

  • 全球市场销售额预测:各地区(2023-2030)
  • 全球市场销售额预测:各国(2023-2030)

第12章 市场区隔

  • 全球市场销售额预测:各疾病(2023-2030)
    • 感染疾病
    • 癌症
    • 肠胃障碍
    • 代谢障碍
  • 全球市场销售额预测:各定序技术类型(2023-2030)
    • 标的遗传基因
    • RNA
    • 全基因霰弹枪
    • 其他类型

第13章 亚太地区市场

第14章 西欧市场

第15章 东欧市场

第16章 北美市场

第17章 南美市场

第18章 中东市场

第19章 非洲市场

第20章 竞争情形

  • 企业简介
  • Seres Therapeutics
  • Assembly Biosciences
  • Enterome Bioscience
  • Vedanta BioSciences
  • Second Genome Inc.

第21章 市场上主要合并和收购

第22章 市场机会与策略

  • 2023年的市场:提供最新机会的国家
  • 2023年的市场:提供最新机会的市场区隔
  • 2023年的市场:成长策略
    • 市场趋势基础的策略
    • 竞争的策略

第23章 结论、建议

  • 结论
  • 建议

第24章 附录

目录

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the human microbiome therapeutics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global human microbiome therapeutics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by disease, and by sequencing technology type.

Market Characteristics - The market characteristics section of the report defines and explains the human microbiome therapeutics market. This chapter also defines and describes products covered in the report.

Trends And Strategies - This chapter describes the major trends shaping the global human microbiome therapeutics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the human microbiome therapeutics market.

Global Market Size And Growth - This section contains the global forecast (2023-2025), (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the forecast periods.

Regional Analysis - This section contains the forecast (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2023-2030) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size forecast (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global human microbiome therapeutics market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for human microbiome therapeutics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global human microbiome therapeutics market is segmented into -

By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases

By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types

Companies Mentioned: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Human Microbiome Therapeutics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography

7. Human Microbiome Therapeutics Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By Disease
    • 7.2.1. Infectious Diseases
    • 7.2.2. Gastrointestinal Disorders
    • 7.2.3. Metabolic Disorders
    • 7.2.4. Cancers
    • 7.2.5. Other Diseases
  • 7.3. Segmentation By Sequencing Technology Type
    • 7.3.1. Targeted Gene
    • 7.3.2. RNA
    • 7.3.3. Whole-Genome Sequencing (WGS)- Shotgun
    • 7.3.4. Others Types

8. Human Microbiome Therapeutics Market Trends And Strategies

  • 8.1. Strategic Collaborations And Agreements
  • 8.2. Increasing Number Of Pipeline Studies And Drug Development
  • 8.3. Increasing Investments On Development Of Cancer Microbiome Therapeutics

9. COVID Impact Human Microbiome Therapeutics Market

10. Global Human Microbiome Therapeutics Market Size And Growth

  • 10.1. Forecast Market Growth, 2023 - 2030, Value ($ Million)
    • 10.1.1. Drivers Of The Market 2023 - 2030
    • 10.1.2. Restraints On The Market 2023 - 2030

11. Human Microbiome Therapeutics Market, Regional Analysis

  • 11.1. Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, Value ($ Million)
  • 11.2. Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, Value ($ Million)

12. Global Human Microbiome Therapeutics Market Segmentation

  • 12.1. Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
    • 12.1.1. Infectious Diseases
    • 12.1.2. Cancers
    • 12.1.3. Gastrointestinal Disorders
    • 12.1.4. Metabolic Disorders
  • 12.2. Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, Value ($ Million)
    • 12.2.1. Targeted Gene
    • 12.2.2. RNA
    • 12.2.3. Whole-genome Shotgun
    • 12.2.4. Other Type

13. Asia-Pacific Human Microbiome Therapeutics Market

  • 13.1. Asia-Pacific Human Microbiome Therapeutics Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Impact of COVID-19
    • 13.1.3. Market Information
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes Levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investment
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.3. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.4. Asia-Pacific Human Microbiome Therapeutics Market: Country Analysis
  • 13.5. China Human Microbiome Therapeutics Market
  • 13.6. China Human Microbiome Therapeutics Market Overview
    • 13.6.1. Country Information
    • 13.6.2. Impact of COVID-19
    • 13.6.3. Market Information
    • 13.6.4. Background Information
    • 13.6.5. Regulations
    • 13.6.6. Regulatory Bodies
    • 13.6.7. Major Associations
    • 13.6.8. Corporate Tax Structure
    • 13.6.9. Investment
    • 13.6.10. Major Companies
  • 13.7. China Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.8. China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.9. India Human Microbiome Therapeutics Market
  • 13.10. India Human Microbiome Therapeutics Market Overview
    • 13.10.1. Country Information
    • 13.10.2. Impact of COVID-19
    • 13.10.3. Market Information
    • 13.10.4. Background Information
    • 13.10.5. Government Initiatives
    • 13.10.6. Regulations
    • 13.10.7. Regulatory Bodies
    • 13.10.8. Major Associations
    • 13.10.9. Corporate Tax Structure
    • 13.10.10. Major Companies
  • 13.11. India Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.12. India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.13. Japan Human Microbiome Therapeutics Market
  • 13.14. Japan Human Microbiome Therapeutics Market Overview
    • 13.14.1. Country Information
    • 13.14.2. Impact of COVID-19
    • 13.14.3. Market Information
    • 13.14.4. Background Information
    • 13.14.5. Regulations
    • 13.14.6. Regulatory Bodies
    • 13.14.7. Corporate Tax Structure
    • 13.14.8. Investment
    • 13.14.9. Major Companies
  • 13.15. Japan Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.16. Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.17. Australia Human Microbiome Therapeutics Market
  • 13.18. Australia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.19. Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.20. Indonesia Human Microbiome Therapeutics Market
  • 13.21. Indonesia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.22. Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.23. South Korea Human Microbiome Therapeutics Market
  • 13.24. South Korea Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.25. South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

14. Western Europe Human Microbiome Therapeutics Market

  • 14.1. Western Europe Human Microbiome Therapeutics Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Impact Of COVID-19
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investment
    • 14.1.12. Major Companies
  • 14.2. Western Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.3. Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 14.4. Western Europe Human Microbiome Therapeutics Market: Country Analysis
  • 14.5. UK Human Microbiome Therapeutics Market
  • 14.6. UK Human Microbiome Therapeutics Market Overview
    • 14.6.1. Country Information
    • 14.6.2. Impact Of COVID-19
    • 14.6.3. Market Information
    • 14.6.4. Background Information
    • 14.6.5. Government Initiatives
    • 14.6.6. Regulations
    • 14.6.7. Regulatory Bodies
    • 14.6.8. Major Associations
    • 14.6.9. Taxes Levied
    • 14.6.10. Corporate Tax Structure
    • 14.6.11. Investment
    • 14.6.12. Major Companies
  • 14.7. UK Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.8. UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 14.9. Germany Human Microbiome Therapeutics Market
  • 14.10. Germany Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.11. Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 14.12. France Human Microbiome Therapeutics Market
  • 14.13. France Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.14. France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

15. Eastern Europe Human Microbiome Therapeutics Market

  • 15.1. Eastern Europe Human Microbiome Therapeutics Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Impact Of COVID-19
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 15.3. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 15.4. Eastern Europe Human Microbiome Therapeutics Market: Country Analysis
  • 15.5. Russia Human Microbiome Therapeutics Market
  • 15.6. Russia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 15.7. Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

16. North America Human Microbiome Therapeutics Market

  • 16.1. North America Human Microbiome Therapeutics Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Impact Of COVID-19
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investment
    • 16.1.12. Major Companies
  • 16.2. North America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 16.3. North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 16.4. North America Human Microbiome Therapeutics Market: Country Analysis
  • 16.5. USA Human Microbiome Therapeutics Market
  • 16.6. USA Human Microbiome Therapeutics Market Overview
    • 16.6.1. Country Information
    • 16.6.2. Impact Of COVID-19
    • 16.6.3. Market Information
    • 16.6.4. Background Information
    • 16.6.5. Government Initiatives
    • 16.6.6. Regulations
    • 16.6.7. Regulatory Bodies
    • 16.6.8. Major Associations
    • 16.6.9. Corporate Tax Structure
    • 16.6.10. Investments
    • 16.6.11. Major Companies
  • 16.7. USA Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 16.8. USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

17. South America Human Microbiome Therapeutics Market

  • 17.1. South America Human Microbiome Therapeutics Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Impact Of COVID-19
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 17.3. South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 17.4. South America Human Microbiome Therapeutics Market: Country Analysis
  • 17.5. Brazil Human Microbiome Therapeutics Market
  • 17.6. Brazil Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 17.7. Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

18. Middle East Human Microbiome Therapeutics Market

  • 18.1. Middle East Human Microbiome Therapeutics Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Impact Of COVID-19
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 18.3. Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

19. Africa Human Microbiome Therapeutics Market

  • 19.1. Africa Human Microbiome Therapeutics Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Impact Of COVID-19
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Taxes Levied
    • 19.1.10. Corporate Tax Structure
    • 19.1.11. Investments
    • 19.1.12. Major Companies
  • 19.2. Africa Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 19.3. Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

20. Global Human Microbiome Therapeutics Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Seres Therapeutics
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Assembly Biosciences
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Enterome Bioscience
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. Vedanta BioSciences
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Second Genome Inc.
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Human Microbiome Therapeutics Market

  • 21.1. Janssen Collaborated With Kaleido Biosciences
  • 21.2. Ritter Pharmaceuticals Merged With Qualigen, Inc.
  • 21.3. Ferring Pharmaceuticals Acquired Rebiotix
  • 21.4. Monsanto Collaborated With Second Genome

22. Human Microbiome Therapeutics Market Opportunities And Strategies

  • 22.1. Global Human Microbiome Therapeutics Market In 2030 - Countries Offering Most New Opportunities
  • 22.2. Global Human Microbiome Therapeutics Market In 2030 - Segments Offering Most New Opportunities
  • 22.3. Global Human Microbiome Therapeutics Market In 2023 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Microbiome Homes Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer